Oncology Institute (TOI) Payables (2020 - 2025)
Historic Payables for Oncology Institute (TOI) over the last 6 years, with Q3 2025 value amounting to $35.6 million.
- Oncology Institute's Payables rose 4501.87% to $35.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.6 million, marking a year-over-year increase of 4501.87%. This contributed to the annual value of $24.3 million for FY2024, which is 6857.72% up from last year.
- Oncology Institute's Payables amounted to $35.6 million in Q3 2025, which was up 4501.87% from $34.9 million recorded in Q2 2025.
- Oncology Institute's Payables' 5-year high stood at $35.6 million during Q3 2025, with a 5-year trough of $24707.0 in Q1 2021.
- In the last 5 years, Oncology Institute's Payables had a median value of $13.9 million in 2022 and averaged $15.9 million.
- Over the last 5 years, Oncology Institute's Payables had its largest YoY gain of 7221632.81% in 2021, and its largest YoY loss of 9142.88% in 2021.
- Quarter analysis of 5 years shows Oncology Institute's Payables stood at $15.6 million in 2021, then tumbled by 39.76% to $9.4 million in 2022, then surged by 53.96% to $14.4 million in 2023, then soared by 68.58% to $24.3 million in 2024, then surged by 46.5% to $35.6 million in 2025.
- Its Payables was $35.6 million in Q3 2025, compared to $34.9 million in Q2 2025 and $29.3 million in Q1 2025.